Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia

By Järbrink Krister   Kreif Noemi   Benedict Agnes   Locklear Julie  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 709-716

Informa Healthcare

Access to resources Recommend Favorite

The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia

By Chue P.   Malla A.   Bouchard R.-H.   Lessard S.   Ganesan S.   Stip E.   Johnson S.   Chen E.   Ahn Y.M.   Kim Y.S.   Robinson G.   Schweikert C.   Gendron A.   Eriksson H.    

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 227-239

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

By Kim Eun Young   Chang Sung Man   Shim Joo Cheol   Joo Eun Jeong   Kim Jae Jin   Kim Yong Sik   Ahn Yong Min  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

By Mercadante Sebastiano  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 661-666

Informa Healthcare

Access to resources Recommend Favorite

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis

By Gotfried Mark   Busman Todd A.   Norris Sandra   Notario Gerard F.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite